28 dez 2004 ano - Cannabis and KYNA
Descrição:
Exogenous cannabinoids such as cannabidiol or Δ9-tetrahydrocannabinol are known to stimulate IDO enzyme activity in dependence of cannabinoid receptor activation [120]. This stimulation, together with the pharmacological inhibition of the kynurenine 3-monooxygenase (KMO) enzyme [123] may enhance endogenous KYNA levels indirectly, through the kynurenine pathway, which will result in an enhanced reduction in NMDA receptor activity via the antagonizing effect of KYNA.
Adicionado na linha do tempo:
New timeline
Data: